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Abstract
Background: Analysing gene expression data from microarray technologies is a very important task in biology and
medicine, and particularly in cancer diagnosis. Different from most other popular methods in high dimensional bio-
medical data analysis, such as microarray gene expression or proteomics mass spectroscopy data analysis, fuzzy
rule-based models can not only provide good classification results, but also easily be explained and interpreted in
human understandable terms, by using fuzzy rules. However, the advantages offered by fuzzy-based techniques in
microarray data analysis have not yet been fully explored in the literature. Although some recently developed
fuzzy-based modeling approaches can provide satisfactory classification results, the rule bases generated by most
of the reported fuzzy models for gene expression data are still too large to be easily comprehensible.
Results: In this paper, we develop some Multi-Objective Evolutionary Algorithms based Interpretable Fuzzy
(MOEAIF) methods for analysing high dimensional bio-medical data sets, such as microarray gene expression data
and proteomics mass spectroscopy data. We mainly focus on evaluating our proposed models on microarray gene
expression cancer data sets, i.e., the lung cancer data set and the colon cancer data set, but we extend our
investigations to other type of cancer data set, such as the ovarian cancer data set. The experimental studies have
shown that relatively simple and small fuzzy rule bases, with satisfactory classification performance, can be
successfully obtained for challenging microarray gene expression datasets.
Conclusions: We believe that fuzzy-based techniques, and in particular the methods proposed in this paper, can
be very useful tools in dealing with high dimensional cancer data. We also argue that the potential of applying
fuzzy-based techniques to microarray data analysis need to be further explored.
Background
Microarray techniques allow simultaneous measuring of
the expression of thousands of genes under different
experimental environments and conditions. They allow
us to analyse the gene information very rapidly by
managing them at one time. The gene expression pro-
files from particular microarray experiments have been
widely used for cancer classification [1-3]. However, the
amount of data produced by this new technology is
usually too large to be manually analysed. Hence, the
need to automatically analyse the microarray data offers
an opportunity for Machine Learning (ML) methods to
have a significant impact on cancer research.
T h ed a t af r o mas e r i e so fm microarray experiments
can be represented as an m × n gene expression matrix
(see Table 1), where each row represents a sample
described by the expression of n genes from one experi-
ment. Each sample belongs to a certain class, i.e., cancer
or non-cancer. Compared to some other classical pro-
blems in machine learning, microarray data sets pose
various problems. The number of features (genes),
usually in the range of 2,000-30,000, is much larger than
the number of examples (usually in the range of 40-
200). In addition, microarray data often brings in multi-
ple missing gene expression values and noisy signals
from the experiments. Therefore, classifying cancer mi-
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dimensional-low-sample data problem with lots of noisy
or missing data.
Unsupervised methods, such as Clustering [4], and
Self-Organizing Maps (SOMs) [5] were initially used to
analyse the relationships among different genes. Subse-
quently, supervised methods, such as Support Vector
Machines (SVMs) [6], Multi-Layer Perceptrons (MLPs
or NNs) [7,8], K Nearest Neighbor (KNN) methods
[9,10], etc., have been successfully applied to the classifi-
cation of different tissues. But, most of the current
methods in microarray data analysis are black box meth-
ods; these models can not satisfactorily reveal the hid-
den information in the data. This information usually
plays a very important role in making a quality clinical
diagnosis.
Different from black-box methods, fuzzy rule-based
models can not only provide good classification results,
but also easily be explained and interpreted in human
understandable terms by using fuzzy rules. This provides
the researchers or clinician an insight into the developed
models. At the same time, fuzzy systems adapt numeri-
cal data (input/output pairs) onto human linguistic
terms and offer very good capabilities of dealing with
noisy and missing data. Compared to other popular
rule-based models in the area, such as C4.5 Decision
Trees (DTs) [11,12], the linguistic rules generated by
our fuzzy-based models are short and easy to be read.
Unfortunately, rule-based methods have suffered some
well-known limitations in dealing with high dimensional
data. Very high dimensional feature vectors and lack of
enough training samples are two major challenges for
modeling microarray data in general, hence for the suc-
cess of applying fuzzy models to this problem too. How-
ever, some recent developments in fuzzy systems
provide us with some good ways to obtain good diagno-
sis results. For example, Vinterbo et al. [13] firstly used
fuzzy rule bases to classify gene expression data, but this
model only allow linear discrimination, and the classifi-
cation performance is limited; an Adaptive-Network-
b a s e dF u z z yI n f e r e n c eS y s t e m( A N F I S )w a ss u c c e s s f u l l y
applied for this problem in [14] too; Woolf and Wang
[15] developed a fuzzy based model to analyse the
relationships between genes, while Ressom et al. [16]
used a clustering-based preprocessing method to
increase the efficiency of the fuzzy models. All these
reported systems are either small models which perform
well on small data sets, or huge models which are diffi-
cult to be understood by the human experts. Other
machine learning techniques, like genetic algorithms
(GA) [17] or ensemble learning [18,19] have been
adopted to allow fuzzy rule-based models to deal with a
relative large number of features, but the obtained rule
bases still look very complex to be easily comprehensi-
ble. Large model complexity significantly damages the
main advantage of applying fuzzy models to this applica-
tion, i.e., the inter-pretability of the models. The compu-
tational cost of constructing these models is generally
very high too.
Normally, the accuracy of each fuzzy rule-based classi-
fier is measured by the number of correctly classified
training or testing patterns, while its in-terpretability is
measured by the complexity of the model, more specifi-
cally, the number of fuzzy rules and the total number of
antecedent conditions. Whereas both accuracy and
interpretability were considered, multi-objective evolu-
tionary based methods are introduced into our systems,
hence, the name of Multi-Objective Evolutionary Algo-
rithms based Interpretable Fuzzy (MOEAIF) models.
We evaluated our proposed model on some well-known
cancer data sets, i.e., the ovarian cancer data set, the
lung cancer data set and the colon cancer data set.
Experimental results are listed and discussed in the later
section. Compared with most previously reported mod-
els, accurate and small fuzzy rule bases were obtained.
Methods
Gene Selection
A major goal for diagnostic research is to develop diag-
nostic procedures based on inexpensive microarrays that
have enough probes to detect certain diseases. This
requires the selection of some genes which are highly
related to the particular classification problem, i.e., the
informative genes. This process is called Gene Selection
(GS), which corresponds to feature selection from any
machine learning task in general. Two basic approaches
for feature selection used in machine learning and infor-
mation theory literature are the filter methods and the
wrapper methods [9,20,20,21]. In theory, wrapper meth-
ods should provide more accurate classification results
than filter methods [21]. The main disadvantage of the
wrapper approach is its computational cost when com-
bined with more complex algorithms such as SVM for
example. The wrapper approach, which is popular in
many machine learning applications, is not extensively
used in DNA microarray tasks, and in most cases the
gene selection is performed by ranking genes on the
Table 1 A typical gene expression matrix X, where rows
represent samples obtained under different experimental
conditions and columns represent genes
Gene 1 Gene 2 … Gene n-1 Gene n Class
1 165.1 276.4 … 636.6 784.9 1
2 653.6 1735.1 … 524.1 104.5 -1
…… … …… … …
m-1 675.0 45.1 … 841.9 782.8 -1
m 78.2 893.8 … 467.9 330.1 1
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tion and sensitivity analysis. More detailed discussions
of these two approaches can be found in [9,20,22-24].
As suggested in [25], a Fuzzy C-Mean Clustering based
Enhanced Gene Selection method (FCCEGS) is applied
in this paper as well for gene selection.
Improved Methods for Obtaining Interpretable Fuzzy
Models
An ideal design of fuzzy rule-based models for microar-
ray data analysis is when we find fuzzy rule-based mod-
els with good interpretability but with acceptable testing
accuracy too. Compared to most popular methods in
cancer microarray gene expression data analysis area,
rule-based fuzzy models usually have relative high com-
putational complexity. In order to obtain good fuzzy
rule-based models, we adopted the following recent
techniques to reduce the complexity of fuzzy rule-based
models.
Weighted Fuzzy Rules
The fuzzy rules Rq used in our models are in the form
of:
￿ Rq:I fx1 is Aq1 and … and xn is Aqn,t h e nC l a s sCq
with CFq.
In the above rule, x =( x1,…,xn) is the n-dimensional
input vector, Aqi is an antecedent fuzzy set for the i – th
input variable, Cq is a consequent class, and CFq is a
c e r t a i n t yd e g r e e( i . e . ,r u l ew e i g h t ) .T h er u l ew e i g h ti sa
real number in the unit interval [0, 1].
Multiple Fuzzy Partitions
For a high-dimensional problem like microarray data
analysis, the antecedent conditions of the generated
rules are normally very numerous. Short fuzzy if-then
rules with only a few antecedent conditions are
obviously easy to understand for human users, and
therefore a novel technique has been applied, as
explained below. We simultaneously generated 14 fuzzy
sets from multiple fuzzy partitions, as shown in Figure
1; “S”, “MS”, “M”, “ML” and “L” denote Small, Medium
Small (relatively small), Medium, Medium Large (rela-
tively large) and Large, respectively. The “don’tc a r e ”
(DC) condition has been added as an additional set.
There are 15 new fuzzy sets in total, and all of these
fuzzy sets are fixed, without any tuning mechanism dur-
ing the training. After training, some fuzzy if-then rules
may have n antecedent conditions (i.e., have no DC con-
ditions), and others may have only a few antecedent
conditions (i.e., have more DC conditions).
Simple Fuzzy Reasoning
Since we have 15 antecedent fuzzy sets for each attri-
bute of our n-dimensional pattern classification pro-
blem, the total number of combinations of the
antecedent fuzzy sets is 15
n. Each combination is used
as the antecedent part Aq of the fuzzy rule Rq. Its
consequent class Cq and rule weight CFqare specified
from compatible training patterns with Aq in the follow-
ing heuristic manner.
First, we calculate the compatibility degree of each
pattern xp with the antecedent part Aq of the rule Rq via
a product operation like:
µAq(xp)=µAq1(xp1) ⋅…⋅µAqn(xpn) (1)
where µAq(￿) is the membership function of Aqi. Then,
t h ec o n f i d e n c eo ft h ef u z z yr u l eAq ⇒ Class h is calcu-
lated for each class h as follows:
cA C l a s sh
x
Ax
q
xC l a s s h A p
qp p
m
pq ()
()
()
, ⇒=
∑ ⊂
= ∑
 
 
m
m
1
(2)
where m denotes the number of training patterns.
The consequent class Cq is specified by identifying the
class with the maximum confidence:
cA C l a s sC cA C l a s sh qq
hM
q () ) m a x( ) ,
,, ,
⇒= ⇒
=
  
12 (3)
where M is the number of classes.
When there is no pattern in the fuzzy sub-space
defined by Aq,w ed on o tg e n e r a t ea n yf u z z yr u l e sw i t h
Aq in the antecedent part. This specification method of
the consequent class of fuzzy rules has been used in a
few studies since early 1990s [26]. It should be noted
that the same consequent class as in Equations 2 and 3
is obtained when we use the support of the fuzzy rule
Aq ⇒ Class h instead of the confidence degree. The sup-
port of the fuzzy rule is calculated as follows:
sA C l a s sh
m
q
xC l a s s h A x pq p () .
()
⇒=
∑ ⊂
 
 
m
(4)
Different specifications for the rule weight CFq have
been proposed and examined. In this paper, we only
consider binary classification problem, we can use the
following specification because good results were pre-
viously reported for that in these papers [27,28]:
CF c A Class C c A Class h qq q q
hh C
M
q
=⇒ − ⇒
=≠ ∑ () ( ) .
,
  
1
(5)
Let S be a subset of candidate fuzzy rules, i.e., a fuzzy
rule-based classifier. Each pattern xp is classified by a
single winner rule Rw, which is chosen from the rule set
S as follows:µAw(xp) ⋅ CFw = max{µAq(xp) ⋅ CFq|Rq Î S}.
We only generate short fuzzy rules with a few antece-
dent conditions, and it should be noted that the DC
conditions can be omitted from fuzzy rules. This restric-
tion is used in order to find a compact set of fuzzy rules
with high interpretability. As for short fuzzy rules, we
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fidence and support as candidate rules for the multi-
objective genetic fuzzy rule selection mechanism.
Rule confidence and support can be used as pre-
screening criteria for finding a tractable number of can-
didate fuzzy rules. The generated fuzzy if-then rules are
then divided into T groups according to their conse-
quent classes, where T is a user-defined parameter.
Fuzzy if-then rules in each group are sorted in the des-
cending order of a pre-screening criterion (i.e. confi-
dence, support, or their product). For selecting Q
candidate rules, the first Q/T rules are chosen from
each of the T groups, and in this manner, we can
choose an arbitrarily specified number of candidate
fuzzy if-then rules (i.e., Q candidate rules). It should be
noted that the aim of the candidate rule pre-screening is
not to construct a fuzzy rule-based system, but to find
candidate rules, from which a small number of fuzzy if-
then rules are later selected. For using a variety of can-
didate rules in rule selection, we choose the same num-
ber of fuzzy if-then rules (i.e., Q/T candidate rules) for
each class. By applying these new techniques, the mod-
els complexity and computational cost is significantly
decreased.
The Multi-Objective Evolutionary Algorithms based
Interpretable Fuzzy (MOEAIF) Model
In this section, we describe how to apply multi-objective
evolutionary algorithms (MOEA) to extract fuzzy rule
sets considering the balance between model accuracy
and model interpretability.
Our task is to select a smaller number of simple fuzzy
if-then rules with high classification performance, and
this is performed by maximizing the classification accu-
racy, minimizing the number of selected rules, and
minimizing the total rule length at the same time.
Therefore, the fitness value of each string S (i.e., each
rule set S) in the current population is defined by the
three objectives using the following fitness function:f(S)
= w1⋅NCCP(S) –w2⋅NOR(S) –w3⋅NOA(S),
where w =( w1, w2,w3), NCCP(S), NOR(S), and NOA(S)
are the weight vector, the number of correctly classified
training patterns, the number of selected fuzzy rules in
S, and the total number of antecedent conditions in S,
respectively. The weights w1,w2,w3 must satisfy the fol-
lowing conditions:w1,w2,w3≥0;w1+w2+w3 =1 ;
As suggested by [29,30], a rule subset R consisting of
the Q candidate rules can be represented by a binary
string as:R = r1r2r3…rQ,
where rq = 0 means that the q-th candidate rule rq is
not included in the rule set R, while rq’ =1m e a n st h a t
rq’ is included in R.
To keep the model complexity low, a simple two-
points crossover strategy is applied to each pair of
parent strings to generate a new string. Biased mutation
is applied to the generated string to efficiently decrease
the number of fuzzy if-then rules included in each
string, that is, different mutation probabilities are used
for the mutation from 1 to 0 and the one from 0 to 1.
For example, the mutation probability from 1 to 0,
PA10
’ , and that from 0 to 1, PA01
’ , are defined as:
PA
w
ww
PA 10
2
13
10
’ ., =
+
(11)
PA
ww
w
PA 01
13
2
01
’ ., =
+
(12)
where w1,w2,w3 are the user defined weights of the
three search objectives in the fitness function, and PA10
and PA10 are two initial fixed parameters. A larger prob-
ability is normally assigned to the mutation from 1 to 0
than to that from 0 to 1, in order to efficiently decrease
the number of fuzzy if-then rules (i.e., the number of
1s) included in each string. By applying the Equations
11 and 12, the mutation rate can be automatically
adjusted according to user different purposes. Our
MOEAIF can be summarized as follows:
1. Step 1: Randomly generate Npop (number of indivi-
duals in the population) binary strings of length Q as an
initial population. Specify the crossover probability pc,
two mutation probabilities, PA10 and PA10, and the stop-
ping condition;
2. Step 2: Generate Npop children strings by applying
crossover and mutation to the current population;
3. Step 3: Calculate the three-objectives fitness value
for each string; unnecessary rules are removed from
each string;
4. Step 4: Update the next population by selecting top
ranked individuals;
5. Step 5: Stop, if the stopping condition is satisfied or
the maximum number of training epochs is reached,
otherwise return to Step 2.
Results and Discussion
Cancer Data Sets
We evaluated our proposed MOEAIF models on three
cancer data sets, namely the ovarian cancer data set, the
lung cancer data set and the colon cancer data set.
￿ Lung Cancer Data Set
Lung Cancer Classification differentiates between
malignant pleural mesothe-lioma (MPM) and adenocar-
cinoma (ADCA) of the lung. There are 181 reported
samples in total, where 31 samples belong to MPM and
150 samples belong to ADCA. The training set contains
32 samples, 16 MPM and 16 ADCA, and the remaining
149 samples are used for testing. The expression levels
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ture represents one probe, for example, the feature
1018.at represents the probe 1018 at. The data is avail-
able at http://cilab.ujn.edu.cn/datasets.htm.
￿ Ovarian Cancer Data Set
The ovarian cancer data set was first reported in [31].
The aim of the experiment was to identify proteomic
patterns in serum that distinguish ovarian cancer from
non-cancer. This study is significant to women who
have a high risk of ovarian cancer due to family or per-
sonal history of cancer. The proteomic spectra were
generated by mass spectroscopy and the raw data can
be found at http://clinicalproteomics.steem.com. There
are 253 reported samples in this data set, where 91 sam-
ples belong to normal and 162 samples belong to ovar-
ian cancers. The normalization is done over all the 253
samples for all 15154 M/Z identities. After the normali-
zation, each intensity value is to fall within the range of
0 to 1. The data is available at http://cilab.ujn.edu.cn/
datasets.htm.
￿ Colon Cancer Data Set
The data set used here was firstly reported in [1]. This
data set contains 62 samples, of which 40 are tumour
samples, and 22 normal samples. About 6000 genes are
represented in each sample in the original data set, out
of which only 2000 were selected. The data is available
at http://sdmc.i2r.astar.edu.sg/rp/ColonTumor/ColonTu-
mor.html.
Accuracy of the MOEAIF Models
Different sets of w1, w2 and w3 are used to simulate dif-
ferent users’ requirements. From Table 2 and Table 3,
we can see that when classification accuracy is preferred,
we can achieve the highest testing accuracy, at 91.28%
on lung cancer data, and 86.71% on ovarian cancer data.
When the interpretability of the models is preferred, we
can use two rules to classify lung cancer data with
89.26% testing accuracy, and three rules to classify lung
cancer data with a testing accuracy of 91.28%. Very
small rule bases for the lung cancer data set are
obtained. Due to lack of enough training examples, a
satisfactory testing accuracy on the colon data set was
not obtained.
Interpretability of the MOEAIF Models
W ef u r t h e re x p l o r et h er u l eb a s eo b t a i n e db yo u r
MOEAIF approach for lung cancer data set, where
w1=0.5, w2=0.3, and w3=0.2.
The whole training process is given in Figure 2. The up
left figure shows the fitness value of the best rule base
found in the population during the training, the up right
figure shows the testing accuracy given by the best rule
base, the total number of fuzzy rules in the rule base is
given in the lower left figure, and the total length of rules
i nt h er u l eb a s ei sg i v e ni nt h el o w e rr i g h tf i g u r e .F r o m
these figures, a wide fluctuation of testing accuracy (right
figure (up)) frequently appears at the early stage of train-
ing. By analyzing the population, we notice this phenom-
enon means there must exist some very strong fuzzy
rules which have large effect on the final classification
result. Including these rules in the selected rule subset
w i l ls i g n i f i c a n t l yc h a n g et h efitness value and classifica-
tion accuracy during training. In the training stage, this
phenomenon can suggest to the users that a small, but
useful fuzzy rule set exists in this data set. A good testing
accuracy is obtained within the first few generations,
which shows that the pre-screening of candidate rules
plays a very important role in this case. Multiple fuzzy
partition technique also helps us avoid the high computa-
tional cost of adjusting fuzzy membership functions like
some previously built fuzzy models.
Compared to the lung cancer data set, it is more diffi-
cult to find an efficient small rule subset for the ovarian
cancer data, see Figure 3, where the name of features
are short for the names of M/Z identities. Ovarian can-
cer data normally require a large number of genes, a
large rule subset and a large number of initial candidate
rules to obtain acceptable testing accuracy. The algo-
rithm can not converge when the number of the input
genes is smaller than 8. Because the pre-processing
stage has already defined a small search space, there is
no need to set the number of generations to be a large
n u m b e r .I tw o u l dn o th e l pt h ea l g o r i t h mt oc o n v e r g ei f
some useful rules are not in the initial rule base, and
the testing accuracy can also be difficult to be further
improved during the training.
Rule Extraction
We can easily extract fuzzy rules from the lung cancer
data set by using a trained MOEAIF model. This fuzzy
Table 2 Classification accuracy and interpretability of
models on the lung cancer data set.
w1 w2 w3 Number of Rules Average Rule Length Testing Accuracy
0.1 0.7 0.2 2 1.5 89.26
0.5 0.1 0.4 6 1.8 90.06
0.5 0.4 0.1 3 2 90.06
0.5 0.2 0.2 3 2 89.93
0.7 0.1 0.2 3 2 91.28
1 0 0 23 2 90.06
Table 3 Classification accuracy and interpretability of
models on the ovarian cancer data set.
w1 w2 w3 Number of Rules Average Rule Length Testing Accuracy
0.7 0.2 0.1 36 2.3 86.71
0.5 0.2 0.3 16 2 78.03
0.3 0.4 0.3 8 2 63.75
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Figure 1 Membership functions from multiple fuzzy partitions. 15 membership functions from four fuzzy partitions of the domain interval
[0, 1]. S, MS, M, ML and L denote Small, Medium Small (relatively small), Medium, Medium Large (relatively large) and Large, respectively. DC
denotes “Don’t Care” membership function.
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Figure 2 The rule extraction process for the lung cancer data set. Left (UP): The fitness value of the best rule base found in the population;
Right (UP): The testing accuracy given by the best rule base; Left (Down): The total number of fuzzy rules in the rule base; Right (Down): The
sum of the length of all rules in the rule base.
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Figure 3 The rule extraction process for the ovarian cancer data set. Left (UP): The fitness value of the best rule base found in the
population; Right (UP): The testing accuracy given by the best rule base; Left (Down): The total number of fuzzy rules in the rule base; Right
(Down): The sum of the length of all rules in the rule base.
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of 0.8993 by using only three rules (see Tables 4). Four
input features are used in the model, i.e., the feature
40256.at, the feature 1018.at, the feature 35792.at and
the feature 33357.at. From this table, we can see that
the rules obtained by our MOEAIF model are linguisti-
cally interpretable, for example:
￿ Rule 1: If the feature 40256.at is “large” and the fea-
ture 33357.at is “large”, then the sample is Cancer with
CF=99.99%.
￿ Rule 2: If the feature 1018.at is “large” and the fea-
ture 33357.at is “medium”, then the sample belongs to
Normal with CF = 98.29%.
￿ Rule 3: If the feature 1018.at is “large” and the fea-
ture 35792.at is “relatively small”, then the sample
belongs to Normal with CF = 97.25%.
The membership functions of the feature 1018.at and
the feature 35792.at in Rule1a r e“dont’tc a r e ”,w h i c h
can reduce the length of Rule1. The rules generated by
our MOEAIF models are shorter than the rules from
our previously built models [14,18,25] and some other
reported rule-based models [11,32].
Table 5 gives a rule base generated for the ovarian
cancer data set by using the MOEAIF approach. The
rule bases generated from the ovarian cancer data set
are normally larger than the rule bases generated from
the lung cancer data set. There are 8 fuzzy rules in this
rule base and the average length of the rules is 2. But
this eight short rules can classify the testing data with
an accuracy of 0.6375. Six features are used in the
model, and the feature MZ6880.2 and the feature
MZ18871.5 play important roles in most of the rules.
Conclusions
In this paper, small and linguistically understandable
fuzzy rule bases were obtained from challenging high
dimensional cancer data sets by using our proposed
Multi-Objective Evolutionary Algorithms based Interpre-
table Fuzzy (MOEAIF) method. The classification per-
formance obtained by our models is also competitive.
We also point out that an ideal design of fuzzy rule-
based models for microarray gene expression data analy-
sis includes two important tasks: designing low-com-
plexity fuzzy models, and finding trade-off points
between classification accuracy and model interpretabil-
ity. We believe that fuzzy techniques and, in particular,
the methods proposed in this paper can be very useful
tools in dealing with microarray data. There also are
Table 4 The selected rule subset for lung cancer data when testing accuracy = 0.8993; “–” denotes “don’t care”
condition.
40256.at 1018.at 35792.at 33357.at CF Class
Rule 1
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
L5
--
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
L5
0.9999 1
Rule 2 -
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
L5
-
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
M5 M5 M5
0.9829 -1
Rule 3 -
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
L5
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
MS4 MS4 MS4
- 0.9725 -1
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MZ820.8 MZ6880.2 MZ1730.9 MZ1866.7 MZ18871.5 MZ827.3 Class
Rule 1 -
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
L5
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
L4
--- 1
Rule 2 -
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
L5
---
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
L4
1 (0.9995)
Rule 3 -
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
S5
--
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
MS5 MS5
- 1 (0.9994)
Rule 4 - - - -
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
S5
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
L5
-1 (0.9999)
W
a
n
g
a
n
d
P
a
l
a
d
e
B
M
C
G
e
n
o
m
i
c
s
2
0
1
1
,
1
2
(
S
u
p
p
l
2
)
:
S
5
h
t
t
p
:
/
/
w
w
w
.
b
i
o
m
e
d
c
e
n
t
r
a
l
.
c
o
m
/
1
4
7
1
-
2
1
6
4
/
1
2
/
S
2
/
S
5
P
a
g
e
8
o
f
1
1Table 5 The selected rule subset for ovarian cancer data when testing accuracy = 0.6375. “–” denotes “don’t care”. (Continued)
Rule 5 - - -
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
L5
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
S4 S4 S4 S4 S4 S4 S4
- -1 (0.9999)
Rule 6 -
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
L5
--
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
S4 S4 S4 S4 S4 S4 S4
- -1 (0.9997)
Rule 7 -
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
L4
--
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
S4 S4 S4 S4 S4 S4 S4
- -1 (0.9996)
Rule 8
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
L4
---
0 0.2 0.4 0.6 0.8 1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
S5
- -1 (0.9994)
W
a
n
g
a
n
d
P
a
l
a
d
e
B
M
C
G
e
n
o
m
i
c
s
2
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1
1
,
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2
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p
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l
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:
S
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:
/
/
w
w
w
.
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.
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1
4
7
1
-
2
1
6
4
/
1
2
/
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2
/
S
5
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a
g
e
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o
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1
1some important issues that need to be addressed in the
future. For example, some microarray gene expression
data sets were generated directly from the probes set,
and in some cases several probes may correspond to the
same gene, or several different genes may hybridise to
the same probes (i.e.,cross-hybridisation). If some of the
input features (or probes) in a single rule are specific to
the same gene(s), then this rule need to be deleted. Due
to lack of enough training examples, satisfactory classifi-
cation results were not always guaranteed in some small
data sets, for example, the colon cancer data set in this
paper.
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